Suppr超能文献

通过粉末衍射对[1,4]二氮杂卓并[6,5-b]吲哚进行结构表征。

Structural characterization of [1,4]diazepino[6,5-b]indoles by powder diffraction.

作者信息

Ryabova Svetlana Yu, Rastorgueva Nina A, Sonneveld Eduard J, Peschar Rene, Schenk Henk, Tafeenko Viktor A, Aslanov Leonid A, Chernyshev Vladimir V

机构信息

Department of Medicinal Chemistry, State Scientific Center of Antibiotics, Nagatinskaya str. 3a, 113105 Moscow, Russia.

出版信息

Acta Crystallogr B. 2005 Apr;61(Pt 2):192-9. doi: 10.1107/S0108768105006075. Epub 2005 Mar 16.

Abstract

As part of a systematic structural study of potentially pharmacologically active [1,4]diazepino[6,5-b]indoles, the crystal structures of nine compounds have been determined from laboratory powder diffraction data. The investigated compounds are: 2-oxo-1-(4-nitrophenyl)-1,2,3,6-tetrahydro[1,4]diazepino[6,5-b]indole-4-oxide, C(17)H(12)N(4)O(4) (1a); 2-oxo-1-phenyl-1,2,3,6-tetrahydro[1,4]diazepino[6,5-b]indole-4-oxide, C(17)H(13)N(3)O(2) (1b); 2-oxo-1-(4-ethoxyphenyl)-1,2,3,6-tetrahydro[1,4]diazepino[6,5-b]indole-4-oxide, C(19)H(17)N(3)O(3) (1c); 2-oxo-1-(4-chlorophenyl)-1,2,3,6-tetrahydro[1,4]diazepino[6,5-b]indole-4-oxide, C(17)H(12)N(3)O(2)Cl (1d); 2-oxo-1-(4-cyanophenyl)-1,2,3,6-tetrahydro[1,4]diazepino[6,5-b]indole-4-oxide, C(18)H(12)N(4)O(2) (1e); 6-methyl-2-oxo-1-phenyl-1,2,3,6-tetrahydro[1,4]diazepino[6,5-b]indole-4-oxide, C(18)H(15)N(3)O(2) (1f); 2-formyl-3-[N'-(omega-chloracetyl)-N'-(4-nitrophenyl)]aminoindole, C(17)H(12)N(3)O(4)Cl (2a); 2-formyl-3-[N'-(omega-chloracetyl)-N'-(4-nitrophenyl)]aminoindole solvate with toluene (2:1), C(17)H(12)N(3)O(4)Cl.0.5C(7)H(8) (2as); 2-formyl-3-[N'-(omega-chloracetyl)-N'-(4-cyanophenyl)]aminoindole, C(18)H(12)N(3)O(2)Cl (2e). Compounds (1a)-(1f) crystallize in non-centrosymmetric triclinic, monoclinic and orthorhombic space groups. The three-dimensional structures of (1a)-(1e) demonstrate identical intermolecular NH(indole)...O<--N hydrogen bonds, which form linear chains of connected molecules. A comparison of the crystal structures (2a), (2e) and (2as) shows that the solvent used in the re-crystallization of (2a) and (2e), which are intermediates in the synthesis of (1a) and (1e), affects the intermolecular hydrogen-bond formation and, as a result, leads to essentially different yields of the goal products.

摘要

作为对具有潜在药理活性的[1,4]二氮杂卓并[6,5 - b]吲哚进行系统结构研究的一部分,已根据实验室粉末衍射数据确定了九种化合物的晶体结构。所研究的化合物为:2 - 氧代 - 1 - (4 - 硝基苯基)-1,2,3,6 - 四氢[1,4]二氮杂卓并[6,5 - b]吲哚 - 4 - 氧化物,C(17)H(12)N(4)O(4) (1a);2 - 氧代 - 1 - 苯基 - 1,2,3,6 - 四氢[1,4]二氮杂卓并[6,5 - b]吲哚 - 4 - 氧化物,C(17)H(13)N(3)O(2) (1b);2 - 氧代 - 1 - (4 - 乙氧基苯基)-1,2,3,6 - 四氢[1,4]二氮杂卓并[6,5 - b]吲哚 - 4 - 氧化物,C(19)H(17)N(3)O(3) (1c);2 - 氧代 - 1 - (4 - 氯苯基)-1,2,3,6 - 四氢[1,4]二氮杂卓并[6,5 - b]吲哚 - 4 - 氧化物,C(17)H(12)N(3)O(2)Cl (1d);2 - 氧代 - 1 - (4 - 氰基苯基)-1,2,3,6 - 四氢[1,4]二氮杂卓并[6,5 - b]吲哚 - 4 - 氧化物,C(18)H(12)N(4)O(2) (1e);6 - 甲基 - 2 - 氧代 - 1 - 苯基 - 1,2,3,6 - 四氢[1,4]二氮杂卓并[6,5 - b]吲哚 - 4 - 氧化物,C(18)H(15)N(3)O(2) (1f);2 - 甲酰基 - 3 - [N'-(ω - 氯乙酰基)-N'-(4 - 硝基苯基)]氨基吲哚,C(17)H(12)N(3)O(4)Cl (2a);2 - 甲酰基 - 3 - [N'-(ω - 氯乙酰基)-N'-(4 - 硝基苯基)]氨基吲哚与甲苯的溶剂化物(2:1),C(17)H(12)N(3)O(4)Cl·0.5C(7)H(8) (2as);2 - 甲酰基 - 3 - [N'-(ω - 氯乙酰基)-N'-(4 - 氰基苯基)]氨基吲哚,C(18)H(12)N(3)O(2)Cl (2e)。化合物(1a) - (1f)以非中心对称的三斜、单斜和正交空间群结晶。(1a) - (1e)的三维结构显示出相同的分子间NH(吲哚)…O<--N氢键,形成连接分子的线性链。对晶体结构(2a)、(2e)和(2as)的比较表明,用于(2a)和(2e)重结晶的溶剂(它们是(1a)和(1e)合成中的中间体)影响分子间氢键的形成,结果导致目标产物的产率有很大差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验